Healthcare
Nordicus – SUCCESS PAGE – February 19, 2025
The only publicly traded business accelerator and holding company in the U.S. for Nordic life science companies.
The only publicly traded business accelerator and holding company in the U.S. for Nordic life science companies.
A clinical-stage precision medicine company enhancing patient outcomes through improved decision-making and personalized cancer care.
The only publicly traded business accelerator and holding company in the U.S. for Nordic life science companies.
A clinical-stage precision medicine company enhancing patient outcomes through improved decision-making and personalized cancer care.
An innovative, clinical stage, drug development company that is creating a potential novel treatment for degenerative eye disease
OncoOne has created a diverse pipeline of treatment options for solid tumor cancers as well as inflammatory diseases including rheumatoid arthritis
An innovative, clinical stage, drug development company that is creating a potential novel treatment for degenerative eye disease
OncoOne has created a diverse pipeline of treatment options for solid tumor cancers as well as inflammatory diseases including rheumatoid arthritis
Bryn is developing a new epinephrine nasal spray that improves on the EpiPen in a number of ways. Most importantly, there are no needles.
Bryn is developing a new epinephrine nasal spray that improves on the EpiPen in a number of ways. Most importantly, there are no needles.
Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates to make cancer less lethal.
Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates to make cancer less lethal.
1460 Broadway
New York, NY 10036
(917) 747-6198
© Copyright 2025 FORCE Family Office
